Key result
Novel RA-RV-Aorta coupling index linked to ~64% lower odds of adverse stage II HLHS outcomes.
Why the study?
Atrioventricular and ventriculoarterial coupling indices have demonstrated prognostic value in various cardiac pathologies, but their utility for predicting adverse outcomes in hypoplastic left heart syndrome had not been studied.
Do novel atrioventricular and ventriculoarterial coupling indices derived from cardiac MRI and invasive hemodynamics improve prediction of adverse clinical outcomes compared to known coupling indices in patients with hypoplastic left heart syndrome and stage II palliation prior to Fontan completion?
Cohort (n=45)
No
Do novel atrioventricular and ventriculoarterial coupling indices derived from cardiac MRI and invasive hemodynamics improve prediction of adverse clinical outcomes compared to known coupling indices in patients with hypoplastic left heart syndrome and stage II palliation prior to Fontan completion?
Novel atrioventricular and ventriculoarterial coupling indices tailored for single ventricle physiology (RAsv-RV and RA-RV-Aorta) outperform standard biventricular AV coupling metrics and provide incremental prognostic value beyond RV-Aortic coupling alone for predicting adverse clinical outcomes in HLHS patients undergoing pre-Fontan evaluation.
Answers are grounded in this paper and cite their sources.
May improve pre-Fontan risk stratification in HLHS; extends coupling indices to single-ventricle physiology but remains hypothesis-generating.
Background Atrioventricular (AV) and ventriculoarterial (VA) coupling indices have demonstrated prognostic value in various cardiac pathologies but have not been studied in hypoplastic left heart syndrome (HLHS). This study assessed known and novel AV and VA coupling indices derived from cardiac MRI (CMR) and invasive hemodynamics for predicting adverse outcomes in HLHS patients with stage II palliation prior to Fontan completion. Methods CMR and catheterization data from 45 HLHS patients with stage II palliation undergoing pre-Fontan evaluation (January 2015–October 2025) were retrospectively analyzed. Known AV coupling indices and two novel indices—RA SV -RV coupling index (RA stroke volume indexed/RV end-diastolic volume indexed) and combined RA-RV-Aorta coupling index—were compared between patients with and without adverse outcomes (composite of death, transplantation, heart failure hospitalization, SGLT2 inhibitor initiation, plastic bronchitis, protein-losing enteropathy). Predictive performance was assessed using Firth logistic regression and ROC analysis. Results Ten patients (22%) experienced adverse outcomes. Known AV coupling indices did not significantly differ between groups (AUC 0.48–0.69). The RV-Aortic coupling index was significantly lower in the adverse outcomes group (0.17 vs. 0.23, p = 0.006; AUC = 0.80). Both novel indices demonstrated superior discrimination: RA SV -RV (0.11 vs. 0.17, p = 0.002; AUC = 0.82) and novel RAsv-RV-Aorta (2.13 vs. 3.90, p = 0.001; AUC = 0.86). Nested models showed that adding each novel index to RV-Aortic coupling significantly improved model fit (p = 0.036 and p = 0.048, respectively). Conclusions Novel coupling indices designed for single ventricle physiology outperformed known AV coupling indices and provided incremental predictive value beyond RV-Aortic coupling alone for adverse outcomes in HLHS patients with stage II palliation.
No takes yet. Share an insight, caveat, or question.
Reid et al. (2026) conducted a cohort in Hypoplastic left heart syndrome (HLHS) with stage II palliation undergoing pre-Fontan evaluation (n=45). Novel RA-RV-Aorta coupling index and RAsv-RV coupling index vs. Known atrioventricular and ventriculoarterial (RV-Aortic) coupling indices was evaluated on Composite adverse clinical outcome (death, heart transplantation, heart failure hospitalization, SGLT2 inhibitor initiation, plastic bronchitis, or protein-losing enteropathy) (OR 0.36, 95% CI 0.12-0.73, p=0.001). Novel RA-RV-Aorta coupling index strongly predicted adverse outcomes in stage II HLHS patients, outperforming known atrioventricular coupling indices.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: